Systematic functional characterization of resistance to PI3K inhibition in breast cancer Journal Article


Authors: Le, X.; Antony, R.; Razavi, P.; Treacy, D. J.; Luo, F.; Ghandi, M.; Castel, P.; Scaltriti, M.; Baselga, J.; Garraway, L. A.
Article Title: Systematic functional characterization of resistance to PI3K inhibition in breast cancer
Abstract: PIK3CA (which encodes the PI3K alpha isoform) is the most frequently mutated oncogene in breast cancer. Small-molecule PI3K inhibitors have shown promise in clinical trials; however, intrinsic and acquired resistance limits their utility. We used a systematic gainof- function approach to identify genes whose upregulation confers resistance to the PI3K inhibitor BYL719 in breast cancer cells. Among the validated resistance genes, Proviral Insertion site in Murine leukemia virus (PIM) kinases conferred resistance by maintaining downstream PI3K effector activation in an AKT-independent manner. Concurrent pharmacologic inhibition of PIM and PI3K overcame this resistance mechanism. We also observed increased PIM expression and activity in a subset of breast cancer biopsies with clinical resistance to PI3K inhibitors. PIM1 overexpression was mutually exclusive with PIK3CA mutation in treatment-naïve breast cancers, suggesting downstream functional redundancy. Together, these results offer new insights into resistance to PI3K inhibitors and support clinical studies of combined PIM/PI3K inhibition in a subset of PIK3CA -mutant cancers. SIGNIFICANCE: PIM kinase overexpression confers resistance to small-molecule PI3K inhibitors. Combined inhibition of PIM and PI3K may therefore be warranted in a subset of breast cancers. © 2016 American Association for Cancer Research.
Journal Title: Cancer Discovery
Volume: 6
Issue: 10
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2016-10-01
Start Page: 1134
End Page: 1147
Language: English
DOI: 10.1158/2159-8290.cd-16-0305
PROVIDER: scopus
PMCID: PMC5050154
PUBMED: 27604488
DOI/URL:
Notes: Article -- Export Date: 6 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Pau Castel
    25 Castel
  2. Jose T Baselga
    484 Baselga
  3. Maurizio Scaltriti
    169 Scaltriti
  4. Pedram Razavi
    172 Razavi